Utama › Penyakit Kardiovaskular › Indiana › Indianapolis
Kajian klinikal Penyakit Kardiovaskular di Indianapolis, IN
16 kajian untuk Penyakit Kardiovaskular sedang mencari peserta di lokasi dalam dan sekitar Indianapolis (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Mengambil pesertaFasa 2
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Mengambil pesertaFasa 3
- American Health Network - Avon, Avon · 13 mi jauh
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
Mengambil peserta
- Ascension Saint Vincent Hospital - Indianapolis, Indianapolis
Product Surveillance Registry
Mengambil pesertaKajian pemerhatian
- Indianapolis, Indianapolis
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Mengambil pesertaFasa 3
- Clinical Trial Site, Avon · 13 mi jauh
- Clinical Trial Site, Whiteland · 16 mi jauh
Zenith® Fenestrated+ Clinical Study
Mengambil peserta
- Methodist Hospital of Indiana, Indianapolis
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Mengambil peserta
- Ascension St. Vincent Hospital - Indianapolis, Indianapolis
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
Mengambil pesertaFasa 3
- Krannert Institute of Cardiology, Indianapolis
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
- Indianapolis VA Medical Center, Indianapolis
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
Mengambil pesertaFasa 3
- Research Site, Indianapolis
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Mengambil pesertaFasa 3
- Franciscan Health Indianapolis, Indianapolis
- Ascension Saint Vincent Heart Center, Indianapolis
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Mengambil peserta
- Ascension St. Vincent's, Indianapolis
Pediatric Cardiomyopathy Mutation Analysis
Mengambil pesertaKajian pemerhatian
- IU School of Medicine, Indianapolis
Molecular Genetics of Heterotaxy and Related Congenital Heart Defects
Mengambil pesertaKajian pemerhatian
- Indiana University School of Medicine, Indianapolis
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Mengambil peserta
- St. Vincent Hospital, Indianapolis
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Mengambil peserta
- Community Health Network, Indianapolis
Kajian Penyakit Kardiovaskular di bandar lain
- Boston, MA37 kajian
- New York City, NY33 kajian
- Washington, DC29 kajian
- Houston, TX24 kajian
- Dallas, TX23 kajian
- Atlanta, GA22 kajian
- Cleveland, OH22 kajian
- Chicago, IL21 kajian
- Philadelphia, PA21 kajian
- Pittsburgh, PA20 kajian
- St. Louis, MO20 kajian
- San Francisco, CA18 kajian
Kajian lain di Indianapolis
- Kanser Paru-paru Bukan Sel Kecil32 kajian
- Kanser (semua jenis)24 kajian
- Kegagalan Jantung23 kajian
- Kanser Payudara20 kajian
- Obesiti20 kajian
- Kanser Metastatik19 kajian
- Kanser Kolorektal18 kajian
- Kanser Ovari17 kajian
- Kanser Paru-paru16 kajian
- Diabetes Jenis 114 kajian
- Kanser Endometrium14 kajian
- Penyakit Alzheimer14 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.